"Bet Hedging" Explains the Efficacy of Many Combination Cancer Therapies

Benefits of many cancer drug combinations are not due to drug synergy, but to "bet hedging." Combinations give each patient multiple chances of responding to at least one drug, increasing survival within patient populations. Findings suggest new ways to improve the design of combination therapies.

Provided by EUPB - Read the full story at the source site.
Read The Full Story

Top News